Raymond Pratt
Directeur Technique/Scientifique/R&D chez SAVARA INC.
Fortune : 712 000 $ au 30/04/2024
Profil
Raymond D.
Pratt is an Independent Director at XORTX Therapeutics, Inc. and the Chief Medical Officer at Savara, Inc. He previously worked as the Assistant Chief & Director-Dialysis Services at Walter Reed Army Medical Center, Senior Director-Clinical Research & Development at Eisai Medical Research, Inc., Vice President-Strategic Drug Development at Quintiles Transnational Corp., Chief Development Officer at Rockwell Medical, Inc., Vice President-Research & Development at Shire Plc and Shire Pharmaceutical Development, Inc., and Assistant Professor at Weill Cornell Medical College and The Johns Hopkins University School of Medicine.
Pratt holds a doctorate degree from the University of Illinois College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAVARA, INC.
0,12% | 14/12/2023 | 160 000 ( 0,12% ) | 712 000 $ | 30/04/2024 |
XORTX THERAPEUTICS, INC.
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Raymond Pratt
| Sociétés | Poste | Début |
|---|---|---|
| XORTX THERAPEUTICS INC. | Directeur/Membre du Conseil | 20/12/2021 |
| SAVARA INC. | Directeur Technique/Scientifique/R&D | 10/11/2022 |
Anciens postes connus de Raymond Pratt
| Sociétés | Poste | Fin |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Directeur Technique/Scientifique/R&D | 20/11/2019 |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/01/2012 |
| SHIRE | Directeur des opérations | 01/01/2010 |
Shire Pharmaceutical Development, Inc.
 Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Directeur Technique/Scientifique/R&D | 01/01/2010 |
| Eisai Medical Research, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Formation de Raymond Pratt
| University of Illinois College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| XORTX THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Walter Reed Army Medical Center | |
| Eisai Medical Research, Inc. | |
Shire Pharmaceutical Development, Inc.
Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Health Technology |
| Savara, Inc. |
